What are the symptoms of MRSA sinus infection. How is MRSA sinus infection diagnosed. What treatments are available for MRSA sinus infection. How can MRSA sinus infections be prevented.

Understanding Staphylococcus Aureus and MRSA

Staphylococcus aureus, commonly known as staph, is a bacterium that frequently colonizes the human body. While it’s often harmless, under certain conditions, it can cause infections ranging from minor skin issues to life-threatening diseases. Methicillin-resistant Staphylococcus aureus (MRSA) is a strain of staph that has developed resistance to many common antibiotics, making it particularly challenging to treat.

Is MRSA always harmful? Not necessarily. Many people carry MRSA on their skin or in their nasal passages without experiencing any symptoms or health issues. However, when MRSA enters the body through a cut, wound, or other means, it can cause serious infections, including sinus infections.

The Prevalence of Staph and MRSA

How common is staph colonization in humans? Studies suggest that between 20-80% of people carry Staphylococcus aureus in their nasal passages. This wide range reflects variations in populations and testing methods. The prevalence of MRSA is generally lower but has been increasing in recent years, particularly in healthcare settings and among certain at-risk populations.

MRSA Sinus Infection: Causes and Risk Factors

MRSA sinus infections occur when the MRSA bacteria enter the sinus cavities and cause inflammation and infection. Several factors can increase the risk of developing an MRSA sinus infection:

• Recent antibiotic use
• Prolonged hospital stays
• Weakened immune system
• Chronic sinus problems
• Nasal surgery or procedures
• Close contact with MRSA-positive individuals

Can nasal habits contribute to MRSA sinus infections? Yes, certain behaviors can increase the risk of introducing MRSA into the sinuses:

• Excessive nose picking
• Frequent nose blowing or rubbing
• Plucking or tweezing nasal hairs

These actions can create small abrasions or breaks in the skin, providing an entry point for MRSA bacteria.

Recognizing MRSA Sinus Infection Symptoms

The symptoms of an MRSA sinus infection can be similar to those of other types of sinus infections. However, MRSA infections may be more severe and resistant to standard treatments. Common symptoms include:

• Facial pain and pressure
• Nasal congestion and discharge
• Reduced sense of smell
• Headache
• Fever
• Fatigue

Are there any unique symptoms that might indicate an MRSA sinus infection? While not definitive, some signs that may suggest MRSA involvement include:

• Persistent or worsening symptoms despite standard antibiotic treatment
• Unusually severe pain or swelling
• Presence of boils or abscesses in or around the nose
• Rapid progression of symptoms

Potential Complications of Untreated MRSA Sinus Infections

If left untreated, MRSA sinus infections can lead to serious complications. These may include:

1. Facial cellulitis: A bacterial infection of the deeper layers of skin
2. Cavernous sinus thrombosis: A blood clot in the hollow space between the brain and eye sockets
3. Osteomyelitis: Infection of the bones in the face or skull
4. Meningitis: Inflammation of the protective membranes covering the brain and spinal cord
5. Orbital cellulitis: Infection of the soft tissues surrounding the eye

How quickly can these complications develop? The progression of MRSA sinus infections can vary, but complications can develop rapidly in some cases, emphasizing the importance of prompt diagnosis and treatment.

Diagnosing MRSA Sinus Infections

Diagnosing an MRSA sinus infection typically involves a combination of clinical evaluation and laboratory tests. The process may include:

1. Medical history review: The doctor will ask about symptoms, recent illnesses, and potential risk factors for MRSA.
2. Physical examination: This includes examining the nose, sinuses, and surrounding areas for signs of infection.
3. Nasal swab: A sample is taken from the inside of the nose to test for the presence of MRSA.
4. Sinus culture: If possible, a sample of sinus drainage may be collected for culture and sensitivity testing.
5. Imaging studies: CT scans or MRI may be used to assess the extent of the infection and rule out complications.

How long does it take to get MRSA test results? Rapid tests can provide preliminary results within hours, but confirmatory culture results typically take 24-48 hours.

Treatment Options for MRSA Sinus Infections

Treating MRSA sinus infections requires a targeted approach due to the bacteria’s resistance to many common antibiotics. Treatment options may include:

Antibiotic Therapy

The choice of antibiotics for MRSA sinus infections depends on the specific strain’s susceptibility pattern. Commonly used antibiotics include:

• Vancomycin
• Linezolid
• Daptomycin
• Trimethoprim-sulfamethoxazole
• Clindamycin

Is intravenous antibiotic treatment necessary for MRSA sinus infections? In severe cases or when oral antibiotics are ineffective, intravenous antibiotics may be required.

Topical Treatments

In addition to systemic antibiotics, topical treatments may be used to reduce MRSA colonization in the nose. These can include:

• Mupirocin ointment
• Chlorhexidine nasal gel
• Povidone-iodine nasal spray

Supportive Care

Supportive measures can help alleviate symptoms and promote healing:

• Saline nasal irrigation
• Over-the-counter pain relievers
• Warm compresses
• Adequate hydration
• Rest

Surgical Intervention

In some cases, surgical intervention may be necessary, particularly if abscesses have formed or if there are complications involving the surrounding structures.

How long does it take to treat an MRSA sinus infection? Treatment duration can vary but typically ranges from 7-14 days for uncomplicated cases, with longer courses necessary for severe or complicated infections.

Preventing MRSA Sinus Infections

Preventing MRSA sinus infections involves a combination of good hygiene practices and targeted strategies to reduce MRSA colonization. Key prevention measures include:

• Practicing good hand hygiene
• Avoiding touching your face, especially your nose, with unwashed hands
• Not sharing personal items like towels, razors, or nasal sprays
• Keeping your nasal passages moist with saline sprays or gels
• Managing underlying conditions that may increase your risk, such as allergies or chronic sinusitis
• Following your healthcare provider’s instructions if you’re known to be colonized with MRSA

Can probiotics help prevent MRSA sinus infections? While research is ongoing, some studies suggest that certain probiotics may help reduce MRSA colonization in the nasal passages. However, more evidence is needed before specific recommendations can be made.

Living with MRSA: Long-term Management and Considerations

For individuals who have experienced an MRSA sinus infection or who are colonized with MRSA, long-term management is crucial. This may involve:

• Regular follow-up with healthcare providers
• Periodic screening for MRSA colonization
• Decolonization protocols as recommended by your doctor
• Vigilant monitoring for signs of recurrent infection
• Education of family members and close contacts about MRSA prevention

Is it possible to completely eliminate MRSA colonization? While decolonization efforts can be successful, complete elimination of MRSA is challenging, and recolonization can occur. The goal is often to manage MRSA colonization and prevent active infections.

Psychological Impact of MRSA Infections

Living with MRSA can have psychological effects, including anxiety about potential infections or transmission to others. It’s important to address these concerns and seek support when needed. Healthcare providers can offer guidance on managing the emotional aspects of MRSA colonization or recurrent infections.

Emerging Research and Future Directions in MRSA Treatment

The field of MRSA research is rapidly evolving, with ongoing efforts to develop new treatment strategies and prevention methods. Some areas of current research include:

• Novel antibiotics effective against MRSA
• Bacteriophage therapy as an alternative to antibiotics
• Immunotherapies to boost the body’s natural defenses against MRSA
• Advanced diagnostic techniques for rapid MRSA detection
• Innovative approaches to biofilm disruption in chronic MRSA infections

What promising treatments are on the horizon for MRSA sinus infections? While still in early stages, researchers are exploring the use of nasal bacteriophage sprays and genetically engineered probiotics as potential treatments for MRSA nasal colonization and infection.

The Role of Antibiotic Stewardship

Antibiotic stewardship programs play a crucial role in combating antibiotic resistance, including MRSA. These initiatives aim to optimize antibiotic use, reduce unnecessary prescriptions, and slow the development of resistant bacteria. Healthcare providers and patients alike have a part to play in responsible antibiotic use.

How can patients contribute to antibiotic stewardship? Patients can help by not pressuring healthcare providers for antibiotics when they’re not necessary, completing prescribed antibiotic courses as directed, and never sharing or using leftover antibiotics.

Special Considerations for High-Risk Populations

Certain groups are at higher risk for MRSA infections, including sinus infections. These populations may require special attention and preventive measures:

• Healthcare workers
• Individuals with frequent hospitalizations
• People with chronic medical conditions
• Athletes in contact sports
• Military personnel
• Residents of long-term care facilities

What additional precautions should high-risk individuals take? High-risk individuals may benefit from regular MRSA screening, more aggressive decolonization protocols, and heightened vigilance for early signs of infection.

MRSA in the Community vs. Healthcare Settings

MRSA infections are often categorized as either community-associated (CA-MRSA) or healthcare-associated (HA-MRSA). While there is some overlap, these strains can differ in their characteristics and treatment approaches:

• CA-MRSA: Often causes skin and soft tissue infections, may be more virulent but potentially more susceptible to certain antibiotics
• HA-MRSA: More likely to cause invasive infections, often more resistant to multiple antibiotics

Do CA-MRSA and HA-MRSA require different treatment approaches for sinus infections? While the fundamental treatment principles are similar, the choice of antibiotics may differ based on the strain’s resistance pattern and the setting in which the infection was acquired.

The Global Impact of MRSA and Antibiotic Resistance

MRSA and other antibiotic-resistant infections represent a significant global health challenge. The World Health Organization (WHO) has identified antibiotic resistance as one of the biggest threats to global health, food security, and development.

Some key points regarding the global impact of MRSA include:

• Increased healthcare costs due to longer hospital stays and more expensive treatments
• Higher mortality rates for infections caused by resistant bacteria
• Challenges in treating common infections as antibiotics become less effective
• Economic impacts due to lost productivity and increased healthcare expenditures

What international efforts are underway to combat MRSA and antibiotic resistance? Global initiatives include surveillance programs to track resistant bacteria, research collaborations to develop new antibiotics, and education campaigns to promote appropriate antibiotic use.

The One Health Approach

The One Health approach recognizes that human health is closely connected to the health of animals and the environment. This concept is particularly relevant to antibiotic resistance and MRSA, as resistant bacteria can spread between humans, animals, and the environment.

How does the One Health approach apply to MRSA prevention? It emphasizes the need for coordinated efforts across human medicine, veterinary medicine, and environmental science to address MRSA and other resistant bacteria holistically.

Staph infection in nose: Symptoms, treatment, and diagnosis

A staphylococcus, or staph, infection is an infection caused by the bacteria Staphylococcus aureus.

Many people carry Staphylococcus aureus (S.aureus) on their skin or within their nose.

Here we look at the various causes and symptoms of a staph infection in the nose. We also outline the available treatment options for a nasal staph infection, as well as some tips for prevention.

Share on PinterestExcessively blowing or rubbing the nose is a possible cause of a staph infection in the nose.

The bacteria S. aureus cause staph infection.

Between 20–80% of humans carry S. aureus within their nasal passages. Most of the time, the bacteria do not cause any harm. However, if the skin of the nose becomes damaged, the bacteria can enter the wound and cause an infection.

Damage to the surface of the skin may trigger a mild to a moderate staph infection. Damage to the deeper layers of the skin may trigger a severe or even life-threatening staph infection.

Staph bacteria are contagious and can spread to other people through:

• skin-to-skin contact
• sharing personal items, such as toothbrushes, razors, or washcloths
• coughing or sneezing, although these types of transmission are less common

A staph infection in the nose can occur as a result of a scratch, sore, or other types of damage to the skin of the nose.

Some potential causes of a nasal staph infection include:

• nose picking
• excessively blowing or rubbing the nose
• plucking or tweezing nasal hairs

A person who has a nasal staph infection may develop the following symptoms:

• redness and swelling of the nose
• crusting around the nostrils
• boils inside one or both nostrils
• facial swelling
• pain
• fever

In some cases, a staph infection may resolve by itself. In other cases, a person will require treatment to clear the infection and prevent further complications.

Some people may succeed in treating minor nasal infections at home. People can soothe sores and crusting by holding a clean, warm, damp cloth onto affected areas. It is important to wash the cloth afterward to avoid spreading the bacteria.

Some people may develop pus-filled boils inside the nostrils. A doctor will need to drain the boil in order to treat the infection and promote wound healing. This procedure typically involves the use of a local anesthetic.

If a nasal staph infection does not clear up by itself, a person may need to take oral antibiotics or apply topical antimicrobial treatments.

Without treatment, staph infections may recur. This is because S.aureus remains inside the nasal passages.

Prescription antibiotic treatments can reduce numbers of staph bacteria, thereby helping to prevent the staph infection from recurring.

Researchers have been investigating the best treatment to prevent recurrent staph infections. According to a 2015 review, topical antimicrobial medications may be more effective than oral antibiotics. This is because S. aureus may have a lower resistance to topical treatments.

Practicing good personal hygiene may also help to reduce the risk of repeat infections.

If a staph infection enters the bloodstream, it can cause serious complications. We list some potential complications below.

Facial cellulitis

Facial cellulitis is a bacterial infection affecting the deeper layers of the skin. Without treatment, the condition can be life-threatening.

Symptoms of facial cellulitis include:

• tenderness and pain in the face
• rash
• skin redness
• lockjaw
• a fever
• chills
• loss of appetite

Cavernous sinus thrombosis

A cavernous sinus thrombosis (CST) is a blood clot that forms in the cavernous sinuses. This is the hollow space between the brain and the eye sockets.

A CST can develop when an infection in the face or skull spreads to the cavernous sinuses. Although rare, the condition can be life-threatening.

Symptoms of a CST include:

• a fever
• a severe headache
• swelling around the eyes
• a weakness of the eye muscles, resulting in drooping eyelids, or double vision
• severe eye pain

Endocarditis

An infection can sometimes spread to the inner lining of the heart chambers and valves. The medical term for this is endocarditis.

Symptoms of endocarditis include:

• a fever
• chills
• fatigue
• aching muscles and joints
• difficulty breathing
• nausea and vomiting
• blood in the urine

Pneumonia

Pneumonia is the medical term for inflammation of one or both lungs. It typically occurs as a result of infection.

In pneumonia, the tiny air sacs, or alveoli, within the lungs fill with fluid or pus. This makes it difficult for a person to breathe.

Some common symptoms of pneumonia include:

• rapid or shallow breathing
• breathlessness, even when resting
• chest pain that worsens when breathing or coughing
• rapid heartbeat
• a fever
• chills
• feeling generally unwell
• loss of appetite

Sepsis

Sepsis is a potentially life-threatening condition in which the body’s immune system overreacts to an infection. This overreaction leads to a toxic build-up of chemicals within the blood.

Symptoms of sepsis include:

• rapid breathing
• increased heart rate
• a fever
• chills
• feeling confused or disorientated

Toxic shock syndrome

Toxic shock syndrome (TSS) is a rare condition in which staph bacteria release dangerous levels of toxins into the bloodstream. TSS can be life-threatening.

The symptoms of TSS come on suddenly and worsen rapidly. They include:

• a fever
• flu-like symptoms, such as a headache, body aches, and a sore throat
• nausea and vomiting
• diarrhea
• a widespread skin rash that appears similar to sunburn
• a bright red coloring of the lips, tongue, and eye-whites
• difficulty breathing
• fainting
• confusion

There are steps a person can take to reduce their risk of developing or spreading a staph infection of the nose or skin. These include:

• regularly washing hands with soap and clean water
• showering or bathing daily to keep skin clean
• covering any cuts or wounds with sterile bandaids or dressings
• avoiding sharing personal items, such as toothbrushes, razors, and washcloths
• covering the mouth and nose when coughing or sneezing
• disposing of tissues after blowing the nose
• avoiding picking the nose
• using only sterile equipment to pluck or tweeze nasal hair, or avoiding these practices altogether

Some staph infections may resolve by themselves, while others may require treatment.

People should see a doctor if the staph infection:

• is severe
• lasts longer than a week, or keeps coming back
• is getting worse, or spreading to other parts of the face
• causes a skin rash or redness
• causes fever or chills
• causes breathing difficulty, or a change in heart rate

Anyone who has a weakened immune system should see a doctor at the first sign of a staph infection. This includes people who:

• are elderly
• have an autoimmune disease
• are receiving chemotherapy
• have received an organ transplant

Staph bacteria commonly live inside the nose and are usually harmless. However, if the skin of the nose becomes damaged, the bacteria can enter the wound and cause infection.

A person who has a nasal staph infection may develop redness, sores, or crusting around the nostrils. A person may need antibiotics or topical antimicrobial medications to treat the infection.

People should seek treatment if their infection is severe or persistent or accompanied by other symptoms. People who have a weakened immune system should seek treatment as soon as possible to reduce the risk of complications.

Staph infection in nose: Symptoms, treatment, and diagnosis

A staphylococcus, or staph, infection is an infection caused by the bacteria Staphylococcus aureus.

Many people carry Staphylococcus aureus (S.aureus) on their skin or within their nose.

Here we look at the various causes and symptoms of a staph infection in the nose. We also outline the available treatment options for a nasal staph infection, as well as some tips for prevention.

Share on PinterestExcessively blowing or rubbing the nose is a possible cause of a staph infection in the nose.

The bacteria S. aureus cause staph infection.

Between 20–80% of humans carry S. aureus within their nasal passages. Most of the time, the bacteria do not cause any harm. However, if the skin of the nose becomes damaged, the bacteria can enter the wound and cause an infection.

Damage to the surface of the skin may trigger a mild to a moderate staph infection. Damage to the deeper layers of the skin may trigger a severe or even life-threatening staph infection.

Staph bacteria are contagious and can spread to other people through:

• skin-to-skin contact
• sharing personal items, such as toothbrushes, razors, or washcloths
• coughing or sneezing, although these types of transmission are less common

A staph infection in the nose can occur as a result of a scratch, sore, or other types of damage to the skin of the nose.

Some potential causes of a nasal staph infection include:

• nose picking
• excessively blowing or rubbing the nose
• plucking or tweezing nasal hairs

A person who has a nasal staph infection may develop the following symptoms:

• redness and swelling of the nose
• crusting around the nostrils
• boils inside one or both nostrils
• facial swelling
• pain
• fever

In some cases, a staph infection may resolve by itself. In other cases, a person will require treatment to clear the infection and prevent further complications.

Some people may succeed in treating minor nasal infections at home. People can soothe sores and crusting by holding a clean, warm, damp cloth onto affected areas. It is important to wash the cloth afterward to avoid spreading the bacteria.

Some people may develop pus-filled boils inside the nostrils. A doctor will need to drain the boil in order to treat the infection and promote wound healing. This procedure typically involves the use of a local anesthetic.

If a nasal staph infection does not clear up by itself, a person may need to take oral antibiotics or apply topical antimicrobial treatments.

Without treatment, staph infections may recur. This is because S.aureus remains inside the nasal passages.

Prescription antibiotic treatments can reduce numbers of staph bacteria, thereby helping to prevent the staph infection from recurring.

Researchers have been investigating the best treatment to prevent recurrent staph infections. According to a 2015 review, topical antimicrobial medications may be more effective than oral antibiotics. This is because S. aureus may have a lower resistance to topical treatments.

Practicing good personal hygiene may also help to reduce the risk of repeat infections.

If a staph infection enters the bloodstream, it can cause serious complications. We list some potential complications below.

Facial cellulitis

Facial cellulitis is a bacterial infection affecting the deeper layers of the skin. Without treatment, the condition can be life-threatening.

Symptoms of facial cellulitis include:

• tenderness and pain in the face
• rash
• skin redness
• lockjaw
• a fever
• chills
• loss of appetite

Cavernous sinus thrombosis

A cavernous sinus thrombosis (CST) is a blood clot that forms in the cavernous sinuses. This is the hollow space between the brain and the eye sockets.

A CST can develop when an infection in the face or skull spreads to the cavernous sinuses. Although rare, the condition can be life-threatening.

Symptoms of a CST include:

• a fever
• a severe headache
• swelling around the eyes
• a weakness of the eye muscles, resulting in drooping eyelids, or double vision
• severe eye pain

Endocarditis

An infection can sometimes spread to the inner lining of the heart chambers and valves. The medical term for this is endocarditis.

Symptoms of endocarditis include:

• a fever
• chills
• fatigue
• aching muscles and joints
• difficulty breathing
• nausea and vomiting
• blood in the urine

Pneumonia

Pneumonia is the medical term for inflammation of one or both lungs. It typically occurs as a result of infection.

In pneumonia, the tiny air sacs, or alveoli, within the lungs fill with fluid or pus. This makes it difficult for a person to breathe.

Some common symptoms of pneumonia include:

• rapid or shallow breathing
• breathlessness, even when resting
• chest pain that worsens when breathing or coughing
• rapid heartbeat
• a fever
• chills
• feeling generally unwell
• loss of appetite

Sepsis

Sepsis is a potentially life-threatening condition in which the body’s immune system overreacts to an infection. This overreaction leads to a toxic build-up of chemicals within the blood.

Symptoms of sepsis include:

• rapid breathing
• increased heart rate
• a fever
• chills
• feeling confused or disorientated

Toxic shock syndrome

Toxic shock syndrome (TSS) is a rare condition in which staph bacteria release dangerous levels of toxins into the bloodstream. TSS can be life-threatening.

The symptoms of TSS come on suddenly and worsen rapidly. They include:

• a fever
• flu-like symptoms, such as a headache, body aches, and a sore throat
• nausea and vomiting
• diarrhea
• a widespread skin rash that appears similar to sunburn
• a bright red coloring of the lips, tongue, and eye-whites
• difficulty breathing
• fainting
• confusion

There are steps a person can take to reduce their risk of developing or spreading a staph infection of the nose or skin. These include:

• regularly washing hands with soap and clean water
• showering or bathing daily to keep skin clean
• covering any cuts or wounds with sterile bandaids or dressings
• avoiding sharing personal items, such as toothbrushes, razors, and washcloths
• covering the mouth and nose when coughing or sneezing
• disposing of tissues after blowing the nose
• avoiding picking the nose
• using only sterile equipment to pluck or tweeze nasal hair, or avoiding these practices altogether

Some staph infections may resolve by themselves, while others may require treatment.

People should see a doctor if the staph infection:

• is severe
• lasts longer than a week, or keeps coming back
• is getting worse, or spreading to other parts of the face
• causes a skin rash or redness
• causes fever or chills
• causes breathing difficulty, or a change in heart rate

Anyone who has a weakened immune system should see a doctor at the first sign of a staph infection. This includes people who:

• are elderly
• have an autoimmune disease
• are receiving chemotherapy
• have received an organ transplant

Staph bacteria commonly live inside the nose and are usually harmless. However, if the skin of the nose becomes damaged, the bacteria can enter the wound and cause infection.

A person who has a nasal staph infection may develop redness, sores, or crusting around the nostrils. A person may need antibiotics or topical antimicrobial medications to treat the infection.

People should seek treatment if their infection is severe or persistent or accompanied by other symptoms. People who have a weakened immune system should seek treatment as soon as possible to reduce the risk of complications.

Methicillin-resistant Staphylococcus aureus (MRSA) facts

1. Home

2. Public Health – Seattle & King County

3. Communicable diseases and immunization

4. Fact sheets and data

5. MRSA

6. MRSA facts

What is MRSA?

MRSA is an acronym for Methicillin-resistant Staphylococcus aureus , a bacterium that is resistant to certain antibiotics. Most MRSA infections cause skin conditions.

What are the symptoms of the disease?

Staphylococcal skin infections usually begin as breaks in the skin, through which bacteria enter the skin and develop into an infection. The set of symptoms includes:

• Local growth or irritation of the skin with characteristic redness, fever, swelling and pain. The affected area may be filled with pus or fluid.
• In some cases, infected individuals may experience fever or chills.
• Staphylococcal infections are often mistaken for bites from venomous arthropods.

How is the disease spread?

• MRSA infection is spread by close contact with the skin of infected individuals or by sharing objects that have been in direct contact with affected skin. Examples of objects that can be shared to spread staph infections include: towels, soap, dressings, bandages, sheets, clothing, sauna benches or hot tubs, and exercise equipment.
• Fluid or pus coming from the affected area is highly contagious.
• Some people carry MRSA in the nose or throat without experiencing symptoms; at the same time, such persons are included in the high-risk group as the most susceptible to infection.

How is MRSA diagnosed and treated?

• MRSA is usually diagnosed by swab analysis of the infected area. In the case of severe disease caused by MRSA infection, tests will help determine the antibiotic that will be effective in treating the infection.
• Treatment may also involve draining the abscess and cleaning the wound with or without antibiotics.
• Severe illness due to MRSA infection involves the use of antibiotics and, in some cases, hospitalization and surgery.

What are the ways to prevent MRSA?

• Keep cuts and scrapes clean and covered/covered.
• Avoid contact with wounds, bandages and dressings of others.
• Consult your physician immediately if you notice reddening of the wound, an increase in its temperature, or a worsening of its condition after treatment.
• Wash your hands regularly.
• Avoid sharing personal hygiene items such as razors.
• Shower after exercise and exercise.

• Last Updated February 14, 2018
• Share
• Tweet
• Print

Methicillin-resistant Staphylococcus aureus of zoonotic origin – a new threat to public health | Vaganova

1. Qin, Y. Antimicrobial Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus Isolates from Child Patients of High-Risk Wards in Shenzhen, China / Y. Qin, F. Wen, Y. Zheng, R. Zhao, Q. Hu, R. Zhang // Jpn J Infect Dis. – 2017. – V. 70, N. 5. – P. 479-484.

2. Rolo, J. Evolutionary Origin of the Staphylococcal Cassette Chromosome mec (SCCmec) / J. Rolo, P. Worning, J.B. Nielsen, R. Bowden, O. Bouchami, P. Damborg, L. Guardabassi, V. Perreten, A. Tomasz, H. Westh, H. de Lencastre, M. Miragaia // Antimicrob Agents Chemother. – 2017. – V.61, N.6. – P. 2302-2316.

3. Wu, S. Tracking the evolutionary origin of the methicillin resistance gene: cloning and sequencing of a homologue of mecA from a methicillin susceptible strain of Staphylococcus sciuri / S. Wu, C. Piscitelli, H. de Lencastre, A. Tomasz // Microcrob Drug Resist. – 1996.-V.2, N.4. – P.435-41.

4. Aires-de-Sousa, M. Methicillin-resistant Staphylococcus aureus among animals: current overview / M. Aires-de-Sousa // Clin Microbiol Infect. – 2017. – V.23, N.6. – P. 373-380.

5. Sahibzada, S. Transmission of highly virulent community-associated MRSA ST93 and livestock-associated MRSA ST398 between humans and pigs in Australia / S. Sahibzada, S. Abraham, G.W. Coombs, S. Pang, M. Hernandez-Jover, D. Jordan, J. Heller // Sci Rep. – 2017. – V.7, N.1. – e. 5273.

6. Brandt, K.M. Evaluation of multiple-locus variable number of tandem repeats analysis for typing livestock-associated methicillin-resistant Staphylococcus aureus / K.M. Brandt, A. Mellmann, B. Ballhausen, C. Jenke, P.J. van der Wolf, E.M. Broens, K. Becker, R. Kock // PLoS One. – 2013. – V.8, N.1. – e54425.

7. Larsen, J. Meticillin-resistant Staphylococcus aureus CC398 is an increasing cause of disease in people with no livestock contact in Denmark, 1999 to 2011 / J. Larsen, A. Petersen, M. Sorum, M. Stegger, L van Alphen, P. Valentiner-Branth, L.K. Knudsen, L.S. Larsen, B. Feingold, L.B. Price, P.S. Andersen, A.R. Larsen, R.L. Skov // Euro Surveill. – 2015. – V.20, N.37.

8. Kinross, P. Livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) among human MRSA isolates, European Union/European Economic Area countries, 2013 / P. Kinross, A. Petersen, R. Skov, E. Van Hauwermeiren , A. Pantosti, F. Laurent, A. Voss A6, J. Kluytmans, M.J. Struelens, O. Heuer, D.L. Monnet // Euro Surveill. – 2017. – V.22, N.44.

9. Gostev, V. Molecular epidemiology and antibiotic resistance of methicillin-resistant Staphylococcus aureus circulating in the Russian Federation / V. Gostev, A. Kruglov, O. Kalinogo-rskaya, O. Dmitrenko, O. Khokhlova, T. Yamamoto , Y. Lobzin, I. Ryabchenko, S. Sidorenko // Infect Genet Evol. – 2017 – V. 53. – P.189-194.

10. Cuny, C. Livestock associated MRSA (LA-MRSA) and its relevance for humans in Germany / C. Cuny, R. Kck, W. Witte // Int J Med Microbiol. – 2013. – V.303, N.6-7. – P.331-337.

11. Larsen, J. Evidence for Human Adaptation and Food-borne Transmission of Livestock-Associated Methicillin-Resistant Staphylococcus aureus / J. Larsen, M. Stegger, P. Andersen, A. Petersen, A.R. Larsen, H. Westh, Y. Agerso, A. Fetsch, B. Kraushaar, A. Kasbohrer, A.T. Fepler, S. Schwarz, C. Cuny, W. Witte, B. Butaye, O. Denis, M. Haenni, J.Y. Madec, E. Jouy, F. Laurent, A. Battisti, A. Franco, P. Alba, C. Mammina, A. Pantos-ti, M. Monaco, J.A. Wagenaar, E. de Boer, E. van Duijkeren, V. Heck M, L. Dominguez, C. Torres, M. Zarazaga, L.B. Price, R.L. Skov // Clin Infect Dis. – 2016. – V.63, N.10. – P.1349-1352.

12. Graveland, H. Livestock-associated methicillin-resistant Staphylococcus aureus in animals and humans / H. Graveland, B. Duim, E. van Duijkeren, D. Heederik, J.A. Wagenaar // Int J Med Microbiol. – 2011. – V.301, N.8. – P.630-634.

13. Neto, A.E.D. Emergence of methicillin-resistant Staphylococcus aureus from clonal complex 398 with no livestock association in Brazil / A.E.D. Neto, R.F.A. Pereira, R.E. Snyder, T.S. Machado, L.S.P. Andre, C.A.A. Cardoso, F. Aguiar-Alves // Mem Inst Oswaldo Cruz. – 2017. – V.112, N.9. – P.647-649.

14. Giacinti, G. Prevalence and characterization of methicil-lin-resistant Staphylococcus aureus carrying mecA or mecC and methicillin-susceptible Staphylococcus aureus in dairy sheep farms in central Italy / G. Giacinti, V. Carfora, A. Caprioli, D Sagrafoli, N. Marri, G. Giangolini, R. Amoruso, M. Iurescia, F. Stravino, S. Dottarelli, F. Feltrin, A. Franco, S. Amatiste, A. Battisti // J Dairy Sci. – 2017.- V.100, N.10. – P.7857-7863.

15. Locatelli, C. Short communication: Methicillin-resistant Staphylococcus aureus in bulk tank milk of dairy cows and effect of swine population density / C. Locatelli, P. Cremonesi, L. Bertocchi, M.G. Zanoni, A. Barberio, I. Drigo, G. Varisco, B. Castiglioni, V. Bronzo, P. Moroni // J Dairy Sci. – 2016.-V.99, N.3. – P.2151-2156.

16. Chen, C.J. Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans / C.J. Chen, T.Y. Lauderdale, C.T. Lu, Y.Y. Chuang, C.C. Yang, T.S. Wu, C.Y. Lee, M.C. Lu, W.C. Ko, Y.C. Huang // J Antimicrob Chemother. – 2018. – V.73, N.1. – P.33-40.

17. Bi, Z. Identical genotypes of community-associated MRSA (ST59) and livestock-associated MRSA (ST9) in humans and pigs in rural China / Z. Bi, C. Sun C, S. Boijesson, B. Chen , X. Ji, B. Berglund, M. Wang, M. Nilsson, H. Yin, Q. Sun, A. Hulth, Y. Wang, C. Wu, Z. Bi, L.E. Nilsson // Zoonoses Public Health. – 2018. – V.65, N.3- P.367-371.

18. Yi, Y. Analysis of the Genetic Diversity in Methicillin-Resistant Staphylococcus aureus Isolates from Bovine Subclinical Mastitis Case in Xinjiang, China / Y. Yi, L. Su, B. Li, S. Li, B. Zhang, Y. Su // Foodborne Pathog Dis. – 2018. – V.15, N.9. – P.568-575.

19. Casey, J.A. Identifying livestock-associated methicil-lin-resistant Staphylococcus aureus in the United States–reply / J.A. Casey, B.S. Schwartz // JAMA Intern Med. – 2014. -V.174, N.5. – P.825.

20. Bosch, T. Livestock-associated MRSA: innocent or serious health threat? / T. Bosch, L.M. Schouls // Future Microbiol. – 2015. – V.10, N.4. – P.445-447.

21. Schulze-Geisthovel, S.V. Survey on the risk awareness of german pig and cattle farmers in relation to dealing with MRSA and antibiotics / S.V. Schulze-Geisthovel, E.V. Tappe, R.M. Schmithausen, J. Lepkojis, K. Rottgen, B. Petersen B2. // Infect Ecol Epidemiol. – 2016. -N.6. – P.29817.

22. Fischer, J. Simultaneous occurrence of MRSA and ES-BL-producing Enterobacteriaceae on pig farms and in nasal and stool samples from farmers / J. Fischer, K. Hille, I. Ruddat, A. Mellmann, R. Kock , L. Kreienbrock // Vet Microbiol. – 2017. – N.200. – P.107-113.

23. Liu, W. The prevalence and influencing factors of meth-icillin-resistant Staphylococcus aureus carriage in people in contact with livestock: A systematic review / W. Liu, Z. Liu, Z. Yao, Y. Fan, X Ye, S. Chen S. // Am J Infect Control. – 2015. -V.43, N.5. – P.469-475.

24. Ye, X. Genotypic and Phenotypic Markers of Livestock-Associated Methicillin-Resistant Staphylococcus aureus CC9 in Humans / X. Ye, X. Wang, Y. Fan, Y. Peng, L. Li, S. Li, J Huang, Z. Yao, S. Chen // Appl Environ Microbiol. – 2016. – V.82, N.13. -P.3892-3899.

25. Jayaweera, J.A.A. S. Antibiotic resistance patterns of methicillin-resistant Staphylococcus aureus (MRSA) isolated from livestock and associated farmers in Anuradhapura, Sri Lanka / J.A.A.S. Jayaweera, W.W. Kumbukgolla // Germs. -2017. – V.7, N.3. – P.132-139.

26. Leibler, J.H. Staphylococcus aureus Nasal Carriage among Beefpacking Workers in a Midwestern United States Slaughterhouse / J.H. Leibler, J.A. Jordan, K. Brownstein, L. Lander, L.B. Price, M.J. Perry // PLoS One. – 2016. – V.11, N.2. – e0148789.

27. Antoci, E. Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among subjects working on bovine dairy farms / E. Antoci, M.R. Pinzone, G. Nunnari, S. Stefani, B. Cacopardo // Infez Med. -2013. – V.21, N.2. – P.125-129.

28. Bal, A.M. Genomic insights into the emergence and spread of international clones of healthcare-, community- and livestock-associated methicillin-resistant Staphylococcus aureus: Blurring of the traditional definitions / A. M. Bal, G.W. Coombs, M.T.G. Holden, J.A. Lindsay, G.R. Nimmo, P. Tattevin, R.L. Skov // J Glob Antimicrob Resist. – 2016. – N.6. – P.95-101.

29. Anker, J.C.H. Distance to pig farms as a risk factor for community-onset livestock-associated MRSA CC398 infection in persons without known contact to pig farms-A nationwide study / J.C.N. Anker, A. Koch, S. Ethelberg, K. Mlbak, J. Larsen, M.R. Jepsen // Zoonoses Public Health. – 2018. – V.65, N. 3. – P.352-360.

30. Bosch, T. Next-Generation Sequencing Confirms Presumed Nosocomial Transmission of Livestock-Associated Methicillin-Resistant Staphylococcus aureus in the Netherlands / T. Bosch, S. Witteveen, A. Haenen, F. Landman, L.M. Schouls // Appl Environ Microbiol. – 2016. – V.82, N.14. – P.40814089.

31. Hatcher, S.M. Occurrence of methicillin-resistant Staphylococcus aureus in surface waters near industrial hog operation spray fields / S.M. Hatcher, K.W. Myers, C.D. Heaney, J. Larsen, D. Hall, M.B. Miller, J.R. Stewart // Sci Total Environ. – 2016. – N.565. – P.1028-1036.

32. Kock, R. Livestock-associated methicillin-resistant Staphylococcus aureus (MRSA) as causes of human infection and colonization in Germany / R. Kock, F. Schaumburg, A. Mellmann, M. Koksal, A. Jurke, K Becker, A.W. Friedrich // PLoS One. – 2013. – V.8, N.2. – e55040.

33. Larsen, J. Emergence of Livestock-Associated Methicil-lin-Resistant Staphylococcus aureus Bloodstream Infections in Denmark / J. Larsen, A. Petersen, A.R. Larsen, R.N. Sieber, M. Stegger, A. Koch, F.M. Aarestrup, L.B. Price, R.L. Skov // Clin Infect Dis. – 2017. – V.65, N.7. – P.1072-1076.

34. Manara, S. Whole-genome epidemiology, characterization, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital / S. Manara, E. Pasolli, D. Dolce, N. Ravenni, S. Campana, F. Armanini , F. Asnicar, A. Mengoni, L. Galli, C. Montagnani, E. Venturini, O. Rota-Stabelli, G. Grandi, G. Taccetti, N. Segata // Genome Med. -2018. -V.10, N.1. – P. 82.

35. Dodemont, M. Emergence of livestock-associated MRSA isolated from cystic fibrosis patients: Result of a Belgian national survey / M. Dodemont, M.A. Argudin, J. Willekens, E. Vanderhelst, D. Pierard, V.Y. Miendje Deyi, L. Hanssens, H. Franckx, P. Schelstraete, I. Leroux-Roels, C. Nonhoff, A. Deplano, C. Knoop, A. Malfroot, O. Denis // J Cyst Fibres. – 2018. – pii: S1569-1993(18)30577-0.

36. Ballhausen, B. LA-MRSA CC398 differ from classical community acquired-MRSA and hospital acquired-MRSA lineages: functional analysis of infection and colonization processes / B. Ballhausen, P. Jung, A. Kriegeskorte, P.E. Makgotlho, U. Ruffing, L. von Muller, R. Kock, G. Peters, M. Herrmann, W. Ziebuhr, K. Becker, M. Bischoff // Int J Med Microbiol. – 2014. – V.304, N.7. – P.777-786.

37. Mutters, N.T. Comparison of livestock-associated and health care-associated MRSA-genes, virulence, and resistance / N.T. Mutters, C.P. Bieber, C. Hauck, G. Reiner, V. Malek, U. Frank // Diagn Microbiol Infect Dis. – 2016. – V.86, N.4. — P.417 — 421.

38. Stevens, M.J.A. Draft Genome Sequence of Staphylococcus aureus S681, a Tetracycline-Sensitive Livestock-Associated Methicillin-Resistant Clonal Complex 398 Strain / M.J.A. Stevens, R. Stephan, S. Johler // Genome Announcement. – 2017. – V. 5, N.33. — e.00805-00817.

39. Larsen, J. Copresence of tet(K) and tet(M) in Livestock-Associated Methicillin-Resistant Staphylococcus aureus Clonal Complex 398 Is Associated with Increased Fitness during Exposure to Sublethal Concentrations of Tetracycline / J. Larsen, J. Clasen, J.E. Hansen, W. Paulander, A. Petersen, A.R. Larsen, D. Frees // Antimicrob Agents Chemother. – 2016. – V.60, N.7. – P.4401-4403.

40. Yan, X. Genetic features of livestock-associated Staphylococcus aureus ST9 isolates from Chinese pigs that carry the lsa(E) gene for quinupristin/dalfopristin resistanc / X. Yan, Z. Li, M.A. Chlebowicz, X. Tao, M. Ni, Y. Hu, Z. Li, H. Grundmann, S. Murray, B. Pascoe, S.K. Sheppard, X. Bo, J.M. Dijl, P. Du, M. Zhang, Y. You, X. Yu, F. Meng, S. Wang, J. Zhang // Int J Med Microbiol. – 2016. – V.306, N.8. — P.722-729.

41. Hau, S.J. Antimicrobial Resistance Distribution Differs Among Methicillin Resistant Staphylococcus aureus Sequence Type (ST) 5 Isolates From Health Care and Agricultural Sources / Hau S.J., J.S. Haan, P.R. Davies, T. Frana, T.L. Nicholson // Front Microbiol. – 2018. – V.9, N.2102.

42. Sieber, R.N. Drivers and Dynamics of Methicillin-Resistant Livestock-Associated Staphylococcus aureus CC398 in Pigs and Humans in Denmark / R.N. Sieber, R.L. Skov, J. Nielsen, J. Schulz, L.B. Price, F.M. Aarestrup, A.R. Larsen, M. Stegger, J. Larsen // MBio. — 2018. — V.9, N.6. — e02142-18.

43. Garcia-Graells, C. Livestock veterinarians at high risk of acquiring methicillin-resistant Staphylococcus aureus ST398 / C. Garcia-Graells, J. Antoine, J. Larsen, B. Catry, R. Skov, O. Denis / / Epidemiol Infect. – 2012. – V.140, N.3. – P.383-389.

44. Luini, M. Methicillin-resistant Staphylococcus aureus (MRSA) is associated with low within-herd prevalence of intramammary infections in dairy cows: Genotyping of isolates / M. Luini, P. Cremonesi, G. Magro, V. Bianchini , G. Minozzi, B. Castiglioni, R. Piccinini // Vet Microbiol. – 2015. – V.178, N. 3-4. – P.270-274.

45. Kraushaar, B. Acquisition of virulence factors in livestock-associated MRSA: Lysogenic conversion of CC398 strains by virulence gene-containing phages / B. Kraushaar, J.A. Hammerl, M. Kienol, M.L. Heinig, N. Sperling, M. Dinh Thanh, J. Reetz, C. Jackel, A. Fetsch, S. Hertwig // Sci Rep. – 2017. – V.7, V.1. — P.2004.

46. Fitzgerald, J.R. Human origin for livestock-associated methicillin-resistant Staphylococcus aureus / J.R. Fitzgerald // MBio. – 2012. – V.3, N.2. — e.00082-12.

47. Harrison, E.M. Whole genome sequencing identifies zoonotic transmission of MRSA isolates with the novel mecA homologue mecC / E.M. Harrison, G.K. Paterson, M.T. Holden, J. Larsen, M. Stegger, A.R. Larsen, A. Petersen, R.L. Skov, J.M. Christensen, A. Bak Zeuthen, O. Heltberg, S.R. Harris, R.N. Zadoks, J. Parkhill, S.J. Peacock, M.A. Holmes // EMBO Mol Med. – 2013. – V.5, N.4. – P.509-515.

48. Perez-Moreno, M.O., Unusual presence of the immune evasion gene cluster in livestock-associated MRSA of lineage CC398 causing peridural and psoas abscesses in a poultry farmer / M.O. Perez-Moreno, M.J. Centelles-Serrano, J. Nogales-Lopez, M.F. Domenech-Spanedda, C. Lozano, C. Torres // En-ferm Infecc Microbiol Clin. — 2017 Dec;35(10):651-654.

49. Gonjalves da Silva, A. A phylogenomic framework for assessing the global emergence and evolution of clonal complex 398 methicillin-resistant Staphylococcus aureus / A. Gonjalves da Silva, S.L. Baines, G.P. Carter, H. Heffernan, N.P. French, X. Ren, T. Seemann, D. Bulach, J. Kwong, T.P. Stinear, B.P. Howden, D.A. Williamson // Microb Genom. – 2017. – V.3, N.1. — e000105.

50. van Alen, S. In the center of an epidemic: Fifteen years of LA-MRSA CC398 at the University Hospital Munster / S. van Alen, B. Ballhausen, G. Peters, A.W. Friedrich, A. Mellmann, R. Kock, K. Becker // Vet Microbiol. – 2017. – N.200. – P.19-24.

51. Kock, R. Characteristics of hospital patients colonized with livestock-associated meticillin-resistant Staphylococcus aureus (MRSA) CC398 versus other MRSA clones / R. Kock, K. Siam, S. Al-Malat, J. Christmann, F Schaumburg, K. Becker, A.W. Friedrich // J Hosp Infect. — 2011. — V.79, N.4. – P.292-296.

52. Reynaga, E. Clinical impact and prevalence of MRSA CC398 and differences between MRSA-TetR and MRSA-TetS in an area of ​​Spain with a high density of pig farming: a prospective cohort study / E. Reynaga, C. Torres , M. Garcia-Nunez, M. Navarro, A. Vilamala, E. Puigoriol, G.E. Lucchetti, M. Sabria // Clin Microbiol Infect. – 2017. – V.23, N.9. — P.678.

53. Hetem, D.J. Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus / D.J. Hetem, M.C. Bootsma, A. Troelstra, M.J. Bonten // Emerg Infect Dis. — 2013. — V.19, N.11. — P.1797-1802.

54. Li, J. Characterization of pig-associated methicillin-resistant Staphylococcus aureus / J. Li, N. Jiang, Y. Ke, A.T. FeBler, Y. Wang, S. Schwarz, C. Wu // Vet Microbiol. – 2017. – N.201. – P.183-187.

55. Sorensen, A.I.V. Risk factors for the occurrence of livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA) in Danish pig herds / A.I.V. Sorensen, V.F. Jensen, A. Boklund, T. Halasa, H. Christensen, N. Toft // Prev Vet Med. — 2018. — N.159. — P.22-29.

56. Bos, M.E. Livestock-associated MRSA prevalence in veal calf production is associated with farm hygiene, use of antimicrobials, and age of the calves / M.E. Bos, H. Graveland, L. Portengen, J.A. Wagenaar, D.J. Heederik // Prev Vet Med. – 2012. – V.105, N.1-2. – P.155-159.

57. Agabou, A. Emergence of Nasal Carriage of ST80 and ST152 PVL+ Staphylococcus aureus Isolates from Livestock in Algeria / A. Agabou, Z. Ouchenane, C. Ngba Essebe, S. Khemissi, M.